PRISM MarketView

TFF Pharmaceuticals’ (TFFP) Thin Film Freezing Technology Demonstrates Superior Pulmonary Drug Delivery

New York, September 26, 2024 - PRISM MarketView - TFF Pharmaceuticals (Nasdaq: TFFP) leads the PRISM Emerging Pharmaceuticals Index with its shares trading up 7% after announcing promising preclinical data published in the “Journal of Drug Delivery Science and Technology...

26 September 2024

Polestar (PSNY) Opens Tech Hub In India Via Partnership with Infosys

New York, September 25, 2024 - PRISM MarketView - PRISM Emerging EV Index company Polestar (PSNY) has entered into a strategic partnership with Infosys (INFY) who is a global leader in next-gen digital services and consulting. This collaboration is focused on supporting ...

25 September 2024

Capricor Therapeutics Announces Plans to File BLA for Deramiocel in the Treatment of Duchenne Muscular Dystrophy Cardiomyopathy, Shares Close Up 52%

New York, September 24, 2024 - PRISM MarketView - Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company focused on cell and exosome-based therapies, has announced its intent to file a Biologics License Application (BLA) for deramiocel (CAP-1002) for the treatment...

25 September 2024

Tilray Unveils New Way to Catch a Beverage Buzz with Delta-9 THC Drink Portfolio To Be Launched in US Markets Next Month

New York, September 24, 2024 - PRISM MarketView - The leading global lifestyle and consumer packaged goods company, Tilray Brands (TLRY) has introduced its new hemp-derived Delta-9 THC beverages (HDD9) via its newly formed Tilray Alternative Beverages business. These bev...

24 September 2024

Edge Impulse and Ceva (CEVA) Collab to Boost Edge AI Applications for Faster and Easier Development

New York, September 24, 2024 - PRISM MarketView - PRISM NextGen Tech and AI Index company Ceva, Inc. (CEVA) is the leading provider of silicon and software IP for Smart Edge devices, and Edge Impulse, a top platform for developing, deploying, and scaling edge machine lea...

24 September 2024

Lipella Pharmaceuticals (LIPO) Announces Early Tolerability Results in Phase 2a Trial for Oral Lichen Planus

New York, September 24, 2024 - PRISM MarketView - Today the clinical stage biopharmaceutical company Lipella Pharmaceuticals (LIPO) reported encouraging tolerability results in its Phase 2a trial for its Oral Lichen Planus (OLP) treatment, LP-310. Three participants hav...

24 September 2024

Vistagen Advances Toward New Social Anxiety Treatment with Phase 3 PALISADE-4 Trial of Fasedienol

New York, September 23, 2024 - PRISM MarketView - Vistagen (Nasdaq: VTGN), a biopharmaceutical company focused on treatments for psychiatric and neurological disorders, has begun enrollment in its PALISADE-4 Phase 3 trial. This trial is part of Vistagen’s ongoing efforts...

23 September 2024

Uranium Energy Corp Leads PRISM MarketView New Energy Index with Acquisition of Rio Tinto's Sweetwater Plant and Wyoming Uranium Assets and Plans to Grow U.S. Production Capacity

New York, September 23, 2024 - PRISM MarketView - Uranium Energy Corp. (NYSE American: UEC) is leading PRISM Market View’s New Energy Index with the news that it has entered into an agreement to acquire Rio Tinto America Inc.’s Wyoming assets. The PRISM Emerging New Ener...

23 September 2024

ChargePoint Expands EV Charging Network with $19M NEVI Award for California Highways

New York, September 23, 2024 - PRISM MarketView - ChargePoint (NYSE: CHPT) has been awarded over $19 million, through its partners, to install 248 DC fast charging ports at 45 locations along California highways. This funding, part of the National Electric Vehicle Infras...

23 September 2024

M&A in Oil and Gas: Battalion Oil (BATL) Soars Over 115% on Acquisition News

New York, September 20, 2024 - PRISM MarketView - PRISM Oil and Gas Index company Battalion Oil Corporation (BATL) has announced an amendment to is previous merger agreement with Fury Resources in which Fury has agreed to acquire all of the outstanding shares of common s...

20 September 2024